Can you tell me the exact date of semaglutide's patent expiry?

When Does Semaglutide's Patent Expire?

The patent for semaglutide, a medication used to treat type 2 diabetes and obesity, has undergone changes in patent ownership and expiration dates [1]. Semaglutide, marketed under the trade name Ozempic among others, is developed by Novo Nordisk.

Semaglutide's original patent, owned by Novo Nordisk, is set to expire on March 6, 2035 [1].

However, generics manufacturers may challenge Novo Nordisk's patent or develop biosimilars before the patent expires. This can lead to earlier availability of cheaper alternative treatments for patients.

It's worth noting that patent expiration dates may change over time due to court decisions or other legal developments. For the most up-to-date information on Semaglutide's patent status, consider checking DrugPatentWatch.com: https://www.drugpatentwatch.com/DrugPatent/14393-1/Ozempic


Sources:
[1] DrugPatentWatch.com: https://www.drugpatentwatch.com/DrugPatent/14393-1/Ozempic